Plenful's AI Tackles Pharmacy's New Medicare Refund Nightmare

SAN FRANCISCO, CA – July 08, 2026 – When the Inflation Reduction Act (IRA) empowered Medicare to negotiate drug prices, it was hailed as a landmark move to lower costs. But for the nation's pharmacies on the front lines of dispensing these medications, the new Maximum Fair Price (MFP) program, which went live this year, has created a severe operational and financial side effect: a complex, fractured, and often broken refund system that leaves them chasing millions in owed revenue. Now, a targeted AI solution is emerging to staunch the bleeding, highlighting a critical trend where automation is becoming essential for navigating modern healthcare regulation.

Plenful, a workflow automation platform specializing in pharmacy operations, today announced its GFI Agent, a new tool designed to automate the recovery of missing MFP refunds. The announcement signals more than just a new product launch; it represents a strategic intervention in a system where up to 20% of expected MFP refunds are reportedly failing to reach pharmacies, creating a significant cash flow crisis and an immense administrative burden.

The Unintended Consequence of Lower Drug Prices

The MFP program was designed with a clear goal: reduce prescription drug costs for Medicare and its beneficiaries. In practice, it dismantled the straightforward reimbursement process pharmacies relied on. Previously, a pharmacy was paid by a Pharmacy Benefit Manager (PBM) in a relatively simple transaction. Under MFP, the process has become a multi-stage relay involving the pharmacy, the PBM, drug manufacturers, and the Centers for Medicare & Medicaid Services (CMS).

Here's the new, convoluted path a payment takes: A pharmacy dispenses an MFP-priced drug and is reimbursed a ceiling price by the PBM. The manufacturer is then responsible for issuing a separate refund to the pharmacy for the difference. This introduces significant delays—often 21 days or more—and multiple points of failure. The complexity is compounded by interactions with other programs, most notably the 340B drug pricing program. Manufacturers, lacking full visibility into whether a claim already received a 340B discount, may incorrectly withhold an MFP refund to avoid a "duplicate discount," leaving the pharmacy short-changed.

The result is a financial quagmire. Plenful's internal data, corroborated by industry chatter, suggests that for high-volume health systems, these missing refunds can accumulate into a massive administrative headache, forcing them to manually investigate and file disputes for hundreds of claims every single month. For an industry already operating on thin margins, this new, unpaid reconciliation work is not just an inconvenience; it's a threat to financial stability.

The Manual Grind of Good Faith Inquiries

To reclaim this missing revenue, pharmacies must engage in the time-sensitive and labor-intensive process of filing a "Good Faith Inquiry" (GFI). These formal disputes must be filed within 120 days of the remittance date, creating a ticking clock for already overworked staff. The process is a brutal, manual grind: staff must identify a discrepancy, locate the original claim, pull the corresponding purchase invoice from wholesaler records, fill out the GFI submission forms for a platform like Beacon's Resolution Center, and then track the outcome. For a single claim, it's tedious. Scaled across thousands of claims, it's an operational nightmare.

"Every month, pharmacy teams are filing hundreds of Good Faith Inquiries by hand, one claim at a time, just to recover money they're already owed," said Joy Liu, founder and CEO of Plenful, in the company's announcement. The statement underscores the sheer inefficiency of the current system. This isn't strategic, value-added work; it's a multi-million-dollar clerical task forced upon healthcare providers by regulatory complexity.

One anonymous revenue cycle director at a multi-state health system described the situation more bluntly. "Before this, we were drowning in paperwork. Now, it feels like the paperwork is on fire. A system that can automate this isn't just a convenience; it's a lifeline."

AI as the Automated Arbitrator

This is the precise pain point Plenful's GFI Agent is built to solve. Rather than just another dashboard, the platform acts as an autonomous agent working on the pharmacy's behalf. By integrating directly with pharmacy management systems, wholesaler EDI feeds, and dispute resolution portals, it transforms the GFI process from a manual chase into a background task.

The system automatically identifies eligible claims with missing refunds and initiates the GFI submission. It pulls and attaches the necessary purchase invoices—a task that can take a human minutes per claim—in seconds. All submissions are tracked in a centralized system, giving finance and pharmacy teams complete visibility into which refunds are pending, approved, or denied. If a GFI is denied, the agent flags it for human review, surfacing the manufacturer's rationale directly in the user interface. It is an end-to-end solution for a uniquely modern problem.

By automating this workflow, the company claims its customers are already saving up to five weeks of staff time annually. This ROI isn't just about cost savings; it's about reallocating highly skilled pharmacy and finance professionals away from administrative drudgery and back toward patient care and strategic financial management. It ensures pharmacies can recover the revenue they are legally owed at the speed and scale the MFP program demands, without hiring a small army of reconciliation clerks.

A Strategic Shift in Healthcare Revenue Management

Plenful's GFI Agent is a microcosm of a much larger trend: the strategic necessity of deploying intelligent automation to manage the growing complexity of the healthcare ecosystem. As government regulations and payment models evolve, the administrative burden on providers invariably increases. Companies that can't adapt their technological infrastructure to absorb this complexity risk being left behind, buried under operational costs and unrealized revenue.

This launch serves as a case study in business innovation. A new, complex regulation created a market need, and a nimble, focused technology company developed a purpose-built solution. While larger, more generalized Revenue Cycle Management (RCM) platforms may eventually address MFP reconciliation, Plenful's specialized, AI-first approach gives it a significant early-mover advantage in this critical niche. It demonstrates that the future of healthcare business operations lies not in simply doing manual work faster, but in automating it intelligently.

As Medicare continues to expand the list of drugs subject to MFP negotiations in the coming years, the problem Plenful is solving will only grow. For business leaders and strategy analysts, the key takeaway is clear: in an era of constant regulatory change, technological agility is no longer just a competitive advantage—it is a core component of financial resilience and sustainable growth.